B

Biohaven Ltd

D

BHVN

USD

0.97

(2.4619%)

Market Closed

41,703.00

حجم التداول

-8.769

الربح لكل سهم

-

العائد الربحي

-4.340860

P/E

3,816,670,753.61

حجم السوق

اليوم

2.4619%

1 اسبوع

12.955%

1 شهر

1.611%

6 اشهر

-29.110%

12 اشهر

123.533%

بداية السنة

-5.678%

كل الوقت

0%

أصول ذات صلة

Title:
Biohaven Ltd

Sector:

Healthcare

Industry:

Biotechnology

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

هل تحتاج مساعدة او لديك استفسار؟

تواصل معنا